- £20.27m
- £20.57m
- £18.76m
- 52
- 34
- 23
- 26
R2018 December 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 15 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.89 | 8.31 | 7.71 | 11.9 | 18.8 |
Cost of Revenue | |||||
Gross Profit | 2.11 | 7.46 | 5.58 | 6.15 | 8.61 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.62 | 10.9 | 8.96 | 12 | 18.5 |
Operating Profit | -2.73 | -2.55 | -1.25 | -0.084 | 0.214 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.73 | -2.67 | -1.32 | -0.157 | 0.152 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.31 | -2.39 | -1.09 | 0.097 | 0.39 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.53 | -5.73 | -1.23 | 0.097 | 0.39 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.53 | -5.73 | -1.23 | 0.097 | 0.39 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.039 | -0.031 | -0.015 | 0.004 | 0.006 |
Dividends per Share |